Next Issue
Volume 12, 05
Previous Issue
Volume 12, 03
 
 
cardiovascmed-logo

Journal Browser

Journal Browser
Cardiovascular Medicine is published by MDPI from Volume 28 Issue 1 (2025). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Editores Medicorum Helveticorum (EMH).

Cardiovasc. Med., Volume 12, Issue 4 (04 2009) – 8 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list.
  • You may sign up for e-mail alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.
Order results
Result details
Select all
Export citation of selected articles as:
3 pages, 75 KB  
Editorial
Bekanntmachungen/Informations
by Cardiovascular Medicine
Cardiovasc. Med. 2009, 12(4), 136; https://doi.org/10.4414/cvm.2009.01411 - 24 Apr 2009
Viewed by 61
Abstract
Regelmässige Veranstaltungen kardiologischer Abteilungen/Colloques des Services de cardiologie [...] Full article
1 pages, 142 KB  
Editorial
Professor Philip Poole-Wilson Stirbt Unerwartet
by Thomas F. Lüscher
Cardiovasc. Med. 2009, 12(4), 135; https://doi.org/10.4414/cvm.2009.01414 - 24 Apr 2009
Viewed by 47
Abstract
Prof. Poole-Wilson, weltbekannter Kardiologe und ehemaliger Präsident der European Society of Cardiology, ist am 4 März 2009 auf dem Weg zu seiner Arbeit in London unerwartet zusammengebrochen und kurz darauf verstorben [...] Full article
1 pages, 117 KB  
Communication
Rapport Annuel 2008 du Groupe de Travail «Lipides et Athérosclérose» (GSLA)
by Rubino Mordasini
Cardiovasc. Med. 2009, 12(4), 134; https://doi.org/10.4414/cvm.2009.01413 - 24 Apr 2009
Viewed by 54
Abstract
Composition du comité de direction: Rubino Mordasini (Président/Délégué de la Fondation Suisse de Cardiologie), Georg Noll (Vice-président), Walter Riesen (Secrétaire/Comité), Richard James (Trésorier/Comité), Marco Roffi (Membre/Comité), Arnold von Eckardstein (Membre/Comité), Edouard Battegay (Membre), Roger Darioli (Membre), Werner Deuel (Membre), Ulrich Keller (Membre), François [...] Read more.
Composition du comité de direction: Rubino Mordasini (Président/Délégué de la Fondation Suisse de Cardiologie), Georg Noll (Vice-président), Walter Riesen (Secrétaire/Comité), Richard James (Trésorier/Comité), Marco Roffi (Membre/Comité), Arnold von Eckardstein (Membre/Comité), Edouard Battegay (Membre), Roger Darioli (Membre), Werner Deuel (Membre), Ulrich Keller (Membre), François Mach (Membre), Giorgio Noseda (Membre), Nicolas Rodondi (Membre), Paolo M. Suter (Membre) [...] Full article
2 pages, 725 KB  
Interesting Images
Obstacles en Série
by Alain Delabays, Philippe Gersbach and Louis Guillou
Cardiovasc. Med. 2009, 12(4), 132; https://doi.org/10.4414/cvm.2009.01409 - 24 Apr 2009
Viewed by 61
Abstract
Description du cas Une femme de 85 ans se présente à l’hôpital pour une dyspnée de repos et une orthopnée d’apparition subaiguë en 2 à 3 semaines [...] Full article
Show Figures

Figure 1

3 pages, 670 KB  
Interesting Images
Electrocardiographic Repolarisation Abnormalities After Acute Organophosphate Poisoning
by Philipp Venetz, Patrik Vanek and Piero O. Bonetti
Cardiovasc. Med. 2009, 12(4), 129; https://doi.org/10.4414/cvm.2009.01410 - 24 Apr 2009
Viewed by 56
Abstract
Case report A 50-year-old man was admitted to our hospital 2.5 h after suicidal ingestion of 100 mL of quinalphos (Ekalux®), an environmental organophosphorus insecticide pollutant [...] Full article
Show Figures

Figure 1

7 pages, 329 KB  
Editorial
L’ivabradine, un Inhibiteur Sélectif du Courant If Sinusal: Une Nouvelle Approche Thérapeutique des Cardiopathies Ischémiques
by François Mach
Cardiovasc. Med. 2009, 12(4), 122; https://doi.org/10.4414/cvm.2009.01412 - 24 Apr 2009
Viewed by 60
Abstract
The selective inhibitor of sinus node If current ivabradine: a new therapeutic approach to ischaemic heart disease.
Coronary artery diseases remain the major cause of morbidity and mortality, and affect public health of industrialised countries. Chronic elevated heart rate is a [...] Read more.
The selective inhibitor of sinus node If current ivabradine: a new therapeutic approach to ischaemic heart disease.
Coronary artery diseases remain the major cause of morbidity and mortality, and affect public health of industrialised countries. Chronic elevated heart rate is a predictive factor for mortality in patients with coronary disease but also in the general population. It is not known whether reduction of heart rate per se can improve outcome of patients with coronary disease. After acute myocardial infarction, several studies with betablockers suggest that a reduced heart rate might be beneficial. However, beta-blockers may be contraindicated in some patients or poorly tolerated. Similarly, lowering heart rate with amiodarone or calcium antagonists is associated with modest event-rate reduction and only in selected patients. The new selective inhibitor of the sinus node If current, ivabradine, looks promising in terms of reducing myocardial ischaemia. The exclusive reduction of heart rate provides comparable efficacy to existing treatments. Ivabradine is very well tolerated and is licensed in Switzerland and Europe for use in stable angina. Full article
Show Figures

Figure 1

8 pages, 168 KB  
Article
Long-Term Coronary Risk in Relation to Exercise Test, SestaMIBI Myocardial Perfusion, Lung Uptake, Transient Ischaemic Dilation and Left Ventricular Volumes
by Michel Romanens, Stefan Goerre, Michael Zellweger and Matthias Pfisterer
Cardiovasc. Med. 2009, 12(4), 114; https://doi.org/10.4414/cvm.2009.01415 - 24 Apr 2009
Cited by 1 | Viewed by 38
Abstract
Purpose: We investigated whether the additional knowledge of lung uptake (lung-heart-ratio, LHR), transient ischaemic dilation (TID) and ungated left ventricular volumes (VOL) on top of perfusion defects (summed stress score [SSS]) derived from a single day rest-stress-technetium-99m SestaMIBI imaging protocol (sd-MPS) improves [...] Read more.
Purpose: We investigated whether the additional knowledge of lung uptake (lung-heart-ratio, LHR), transient ischaemic dilation (TID) and ungated left ventricular volumes (VOL) on top of perfusion defects (summed stress score [SSS]) derived from a single day rest-stress-technetium-99m SestaMIBI imaging protocol (sd-MPS) improves prediction of major cardiac events (MACE) in the long-term. SSS together with exercise SestaMIBI measurements provide important prognostic information. However, little is known about the incremental prognostic value of LHR, TID, and VOL. Methods: In a primary care outpatient setting, 519 patients underwent a supine bicycle electrocardiogram stress test (EST) as specified by an sd-MPS protocol. SSS, TID, and VOL were quantified with AutoQUANT (version 4.3). LHR was measured from a planar anterior image 4–6 minutes after peak exercise. The mean follow-up period was 6.1 ± 1.5 years. Results: The mean patient age was 59 ± 11 years. Of the 519 patients, 363 (70%) were male and 236 (45%) had known coronary artery disease. There were 44 major cardiac events, thereof 32 cardiac deaths and 12 nonfatal myocardial infarctions. Using Cox analysis for EST and scintigraphic variables, the independent predictors of MACE were male gender, the cardiac workload level reached during testing, and VOL. When a Cox-proportional Hazard model was used, LHR (X2 = 26.83, p = 0.04) and VOL (X2 = 69.55, p < 0.001) showed a significant increase in the prognostic value over standard stress test and SSS measures. Conclusions: The strongest predictors of MACE were VOL. LHR, but not TID added incremental prognostic information to perfusion data. Full article
Show Figures

Figure 1

5 pages, 345 KB  
Editorial
Biomarker als Schlüssel zur Neuen Definition des Myokardinfarkts
by Walter F. Riesen
Cardiovasc. Med. 2009, 12(4), 109; https://doi.org/10.4414/cvm.2009.01416 - 24 Apr 2009
Cited by 1 | Viewed by 48
Abstract
Biomarkers: the key for the new definition of myocardial infarction
In the new joint guidelines of international scientific societies for the definition of myocardial infarction cardiac biomarkers, especially the cardiac troponins T and I play a central role as a diagnostic criterion in [...] Read more.
Biomarkers: the key for the new definition of myocardial infarction
In the new joint guidelines of international scientific societies for the definition of myocardial infarction cardiac biomarkers, especially the cardiac troponins T and I play a central role as a diagnostic criterion in NONSTEMI. These markers are suitable for risk stratification and provide prognostic information. As new cut-off point the 99th percentile of a healthy reference population was chosen. Moreover an analytical imprecision of less than 10% coefficient of variation at the cut-off point is required by the guidelines. The diagnosis of myocardial infarction includes an appropriate clinical diagnosis and the kinetic of the troponin increase, because increased troponin levels as a sign of myocardial damage may also occur in patients without coronary heart disease. The new definition will lead to an apparent increase in myocardial infarction (according to the AMIS registry in Switzerland by about 6%). It will also have consequences for the patients (psychological, insurance, at the working place, for certain activities, etc). Data from high risk patients with acute coronary syndrome indicate that every measurable troponin value (even below the 99th percentile) is associated with an increased risk. This justifies apart from the standardisation the lowering of the cut-off to the 99th percentile. Full article
Show Figures

Figure 1

Previous Issue
Next Issue
Back to TopTop